Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Comment by TheKing1021on Dec 14, 2017 6:21pm

34 Views

Post# 27160305

RE:RE:What's your angle?

The difference is, I own shares and he doesn't and you probably don't either. Also radar cannot even read a news release. Stated human trials starting in a month (nov 29) NR and it would take 4 months to complete the study approx and that the study would be "open" for 9 months in total for quality insurance type of stuff. FDA approval is 3-4 months out as well. I've done my DD and have spoken with the CEO so go pound sand.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading